Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
J Anesth. 2013 Oct;27(5):731-41. doi: 10.1007/s00540-013-1615-7. Epub 2013 May 14.
Despite the development of effective chemotherapy and radiotherapy, surgery remains the mainstay treatment of many cancers, requiring anesthesia. Almost all cancer deaths after primary surgery are attributable to recurrence or metastases. Recently it has been hypothesized that the perioperative anesthetic management of cancer patients could potentially affect the risk of recurrence and metastases, which implies a key role for anesthesiologists in choosing anesthetic agents and techniques that optimize the balance between the metastatic potential of the tumor versus its elimination by antimetastatic immune defenses. This review summarizes available experimental information on the potential effects of common anesthetic agents and techniques on cancer metastases and the conflicting retrospective clinical data on regional anesthesia in various types of cancer. A number of prospective, randomized, multicenter, clinical trials are in progress, and their results are eagerly awaited.
尽管有效的化疗和放疗已经发展起来,但手术仍然是许多癌症的主要治疗方法,需要麻醉。几乎所有原发性手术后癌症死亡的原因都是复发或转移。最近有人假设,癌症患者围手术期的麻醉管理可能会影响复发和转移的风险,这意味着麻醉师在选择麻醉剂和技术方面发挥着关键作用,这些技术可以优化肿瘤的转移潜力与其抗肿瘤免疫防御之间的平衡。这篇综述总结了关于常见麻醉剂和技术对癌症转移的潜在影响的现有实验信息,以及关于区域麻醉在各种癌症中的回顾性临床数据的矛盾。一些前瞻性、随机、多中心的临床试验正在进行中,人们急切地等待着这些试验的结果。